The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis
Abstract Objective To systematically evaluate the incidence of hypokalemia associated with novel androgen receptor axis-targeted therapies (ARATs)—specifically abiraterone, enzalutamide, and their combination—in patients with advanced prostate cancer. Methods A comprehensive search of PubMed, Embase...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2026-07-01
|
| Collection: | BMC Cancer |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12885-026-16108-w |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|